Cell Signaling Technology, Inc.

Danvers, MA

UEI
DEUMJK7A3NH4
CAGE
3LTH3
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3 Trask Ln, Danvers, MA 01923, USA
Website
cellsignal.com
Founded
1999
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $37,968
FY2024 $52,000
FY2023 $224,000

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Similar vendors

About the company

Cell Signaling Technology, Inc. is a private, family-owned company based in Danvers, Massachusetts, that specializes in developing and producing advanced scientific research products, particularly antibodies, kits, and reagents used to study cell signaling pathways. Registered in SAM.gov since 2003, the company is structured as a for-profit corporate entity and a manufacturer of goods, with a primary focus on applied systems biology research related to cancer and biomedical sciences. The company has demonstrated a strong capability in providing specialized scientific services to various federal agencies, primarily within the National Institutes of Health (NIH) ecosystem.

The federal contract awards reveal that Cell Signaling Technology, Inc. provides sophisticated scientific research services across multiple federal agencies, predominantly within the NIH network. These services include proteome analysis, mass spectrometry, tandem mass tag (TMT) profiling, and specialized antibody and reagent procurement for advanced scientific experiments. Specific contract awards include a $224,000 proteome analysis service for the National Heart, Lung and Blood Institute, a $52,000 global TMT profiling analysis for the National Human Genome Research Institute, and multiple purchase orders for antibodies and research materials from agencies like the National Institute on Drug Abuse (NIDA) and the National Institute of Allergy and Infectious Diseases (NIAID). None of these contracts utilized set-aside designations, indicating the company competes on an unrestricted basis. The contract values range from approximately $13,000 to $224,000, with performance periods typically spanning several months to a year, and focus primarily on supporting advanced biomedical and cancer-related research initiatives.

Quick answers

Is Cell Signaling Technology, Inc. registered in SAM.gov?

Yes. Cell Signaling Technology, Inc.'s SAM.gov registration is active through November 20, 2026.

What is Cell Signaling Technology, Inc.'s CAGE code?

Cell Signaling Technology, Inc.'s CAGE code is 3LTH3, and its Unique Entity ID (UEI) is DEUMJK7A3NH4.

How much has Cell Signaling Technology, Inc. received in federal contracts?

Federal contracts obligated $37,968 to Cell Signaling Technology, Inc. in fiscal year 2025 and $313,968 in fiscal years 2023 through 2027.

What is Cell Signaling Technology, Inc.'s most recent federal award?

Cell Signaling Technology, Inc.'s most recent federal contract award is Nida lab requires antibodies in order to support ongoing experiments (75N95025P00391), from National Institute on Drug Abuse (NIH), on September 9, 2025.

On GovTribe

See Cell Signaling Technology, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe